MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Prepaid expenses andother current assets$1,298K Cash and cashequivalents$133,265K Other assets$1,253K Restricted cash$107K Operating leaseright-of-use assets$1,564K Property and equipment,net$782K Total current assets$134,563K Total assets$138,269K Total liabilities,convertible preferred...$138,269K Total shareholders'equity (deficit)$116,641K Total liabilities$21,628K Accumulated deficit-$79,412K Additional paid-in capital$192,039K Operating leaseliability, noncurrent$1,324K Total currentliabilities$20,304K Ordinary shares, 0.001par value...$14K Series a non-votingconvertible preferred...$4,000K Warrant liability,related party$2,088K Operating leaseliability, current$417K Related party accountspayable and other...$6,273K Accrued expenses andother current...$8,965K Accountspayable-Nonrelated Party$2,561K
Balance Sheet
source: myfinsight.com

CRESCENT BIOPHARMA, INC. (CBIO)

CRESCENT BIOPHARMA, INC. (CBIO)